Your browser doesn't support javascript.
loading
Enhanced antitumor efficacy of bile acid-lipid complex-anchored docetaxel nanoemulsion via oral metronomic scheduling.
Jha, Saurav Kumar; Chung, Jee Young; Pangeni, Rudra; Choi, Hyeong Seok; Subedi, Laxman; Kweon, Seho; Choi, Jeong Uk; Byun, Youngro; Kim, Yong-Hee; Park, Jin Woo.
Affiliation
  • Jha SK; Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Mokpo National University, Muan-gun, Jeonnam 58554, Republic of Korea.
  • Chung JY; Department of Bioengineering, Hanyang University, Seongdong-gu, Seoul 04763, Republic of Korea; Department of Bioengineering, Institute for Bioengineering and Biopharmaceutical Research, BK21 Plus Future Biopharmaceutical Human Resources Training and Research Team, Hanyang University, Seongdong-gu,
  • Pangeni R; College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Muan-gun, Jeonnam 58554, Republic of Korea.
  • Choi HS; Department of Bioengineering, Hanyang University, Seongdong-gu, Seoul 04763, Republic of Korea.
  • Subedi L; Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Mokpo National University, Muan-gun, Jeonnam 58554, Republic of Korea.
  • Kweon S; Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Choi JU; College of Pharmacy, Chonnam National University, Gwangju 61186, Republic of Korea.
  • Byun Y; Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
  • Kim YH; Department of Bioengineering, Hanyang University, Seongdong-gu, Seoul 04763, Republic of Korea; Department of Bioengineering, Institute for Bioengineering and Biopharmaceutical Research, BK21 Plus Future Biopharmaceutical Human Resources Training and Research Team, Hanyang University, Seongdong-gu,
  • Park JW; Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Mokpo National University, Muan-gun, Jeonnam 58554, Republic of Korea; College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Muan-gun, Jeonnam 58554, Republic of Korea. Electronic address:
J Control Release ; 328: 368-394, 2020 12 10.
Article in En | MEDLINE | ID: mdl-32890552
ABSTRACT
In this study, a system for oral delivery of docetaxel (DTX) was prepared to enhance the oral absorption and anticancer efficacy of DTX via metronomic chemotherapy. DTX was complexed with low-molecular-weight methylcellulose (LMC) and loaded into a nanoemulsion (NE), yielding DTX/LMC-NE (DLNE). To further enhance the oral bioavailability, d-alpha-tocopherol polyethylene glycol succinate and sodium deoxycholate (DOCA) complexed with cationic lipid 1,2-dioleyl-3-trimethylammonium propane (DOTAP) (DOCA-DOTAP [DA-TAP] complex) was incorporated into DLNE, yielding the formulation DLNE#10. As expected, DLNE#10 showed 11.3- and 5.81-fold increases in artificial membrane (Pe) and Caco-2 permeability (Papp), respectively, resulting in 249% greater oral bioavailability, compared to free DTX. In contrast, inhibition of clathrin- and caveola-mediated endocytosis, macropinocytosis, and bile acid transporters by chlorpromazine, genistein, amiloride, and actinomycin D in the Caco-2 monolayer reduced the Papp by 55.3%, 44.2%, 35.9%, and 36.5%, respectively; these findings suggest that these routes play important roles in enhancing the oral absorption of DLNE#10. In addition, our mechanistic study suggested that P-glycoprotein (P-gp) did not have an inhibitory effect on the permeation of DLNE#10. Notably, the half-maximal inhibitory concentrations (IC50) of DLNE#10 were 43.5% and 16.8% greater than those of Taxotere® in MCF-7 and 4T1 cells, respectively. Finally, the tumor inhibitory rates in 4T1 cell tumor-bearing mice after oral metronomic dosing of DLNE#10 (20 mg/kg DTX) were 5.02- and 1.65-fold greater than the rates in the untreated control group and intravenously injected DTX (10 mg/kg) group, respectively. These observations support the improved oral absorption and enhanced chemotherapeutic efficacy of DTX in DLNE#10 via metronomic chemotherapy, suggesting that it is a better alternative than intravenous Taxotere®.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: J Control Release Journal subject: FARMACOLOGIA Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: J Control Release Journal subject: FARMACOLOGIA Year: 2020 Document type: Article